Welcome to our dedicated page for High Tide news (Ticker: HITI), a resource for investors and traders seeking the latest updates and insights on High Tide stock.
High Tide Inc. (HITI) generates frequent news as a cannabis-focused retail and distribution company with operations in Canada, Germany, and global e-commerce. News about High Tide often centers on the expansion of its Canna Cabana retail chain, developments in its medical cannabis distribution business in Germany, and updates related to its hemp-derived CBD brands and online platforms.
Investors and followers of HITI can expect regular announcements about new Canna Cabana store openings across Canadian provinces such as Alberta and Ontario, as well as updates on international locations like the Berlin Canna Cabana store. These releases typically describe store locations, local market characteristics, and how new sites fit into High Tide’s broader retail strategy and discount club model.
High Tide’s news flow also includes participation in investor conferences, recognition in business rankings, and commentary on regulatory developments affecting cannabis and CBD markets. The company has issued news about being named to Canada’s Top Growing Companies list and about its ranking on the Financial Times list of Americas’ Fastest Growing Companies. It also publishes releases related to corporate milestones, such as entering the German medical cannabis market through Remexian Pharma GmbH.
On Stock Titan’s HITI news page, readers can review these company-issued updates in one place, including store expansion announcements, international growth initiatives, and regulatory or policy commentary that High Tide chooses to highlight. This makes the page a useful reference for tracking how the company describes its strategy, geographic footprint, and operational progress over time.
High Tide (Nasdaq: HITI) announced it is proactively investigating unusual trading patterns in its common shares, including lower next-day closes following earnings releases. The company will retain forensic market-structure specialists, cooperate with Canadian and U.S. regulators, and invite shareholders to submit relevant information to ir@hightideinc.com.
High Tide (NASDAQ: HITI) opened a new Canna Cabana retail store in Caledonia, Ontario, beginning sales of recreational cannabis and accessories on April 20, 2026. The opening increases the company's footprint to 221 Canna Cabana locations in Canada and 97 in Ontario, and the business cites a 12% Canadian market share for its Canadian bricks-and-mortar operations.
The Caledonia site is positioned at the town's south end near other national retailers and aims to serve Caledonia and surrounding Haldimand County trade areas.
High Tide (Nasdaq: HITI) announced senior executives and advisors will speak at multiple cannabis and investor conferences in Europe and North America between April and June 2026.
Planned appearances include Berlin (April 13–14), New York (May 7, June 2), London (May 26) and Las Vegas (June 17). The company highlights its retail scale (Canna Cabana: 220 Canadian locations, 1 international) and medical distribution reach (Remexian licensed to import from 19 countries).
High Tide (NASDAQ: HITI) said its U.S. CBD subsidiary NuLeaf Naturals intends to pursue participation in CMS Innovation Center's Beneficiary Engagement Incentive (BEI) pilot launching April 1, 2026. The program allows participating ACO REACH and EOM organizations to furnish eligible hemp-derived CBD products to Medicare beneficiaries, up to US$500 per beneficiary per year. CMS may expand BEI to the LEAD Model on Jan 1, 2027. NuLeaf highlights cGMP-certified, FDA-registered manufacturing and product formats aligned to pilot compliance.
High Tide (NASDAQ: HITI) reported record revenue of $178.3M for Q1 FY2026, up 25% YoY, record gross profit of $44.4M (+25% YoY), and Adjusted EBITDA of $11.5M. The company generated $2.9M free cash flow in the quarter and reduced net loss to $0.4M. Retail loyalty membership exceeded 2.58M in Canada, and medical segment momentum increased after the Remexian acquisition.
High Tide (Nasdaq: HITI) opened its 220th Canna Cabana retail store at 1355 London Road in Sarnia, Ontario, beginning sales on March 9, 2026. This is the company’s first Sarnia location and increases its Ontario footprint to 96 stores.
The company said Canna Cabana now operates 220 locations nationwide and holds a growing 12% Canadian market share. High Tide will release Q1 2026 results after markets close on March 17, 2026, with a management webcast at 11:30 AM ET on March 18, 2026.
High Tide (Nasdaq: HITI) and its U.S. hemp-derived CBD subsidiary NuLeaf Naturals joined the U.S. National Compassionate Care Council as founding members on March 4, 2026.
The companies said this role aims to help modernize medical cannabis policy, improve patient access to cannabinoid therapies, and contribute industry expertise amid federal rescheduling and Medicare reimbursement discussions.
Other founding members include Feals, Medterra, Tilray, Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria.
High Tide (Nasdaq: HITI) announced board renewal effective March 2, 2026, naming Kathleen Skerrett and Menashe Kestenbaum as directors and adding David Wallach and Filip Ernest to the advisory board.
The company granted 123,558 RSUs and 25,000 options at a $3.43 strike for three years to directors, advisors and consultants, and highlighted retail scale (219 Canadian locations, ~12% domestic share) and expanded tech/AI and real estate expertise.
High Tide (Nasdaq: HITI) opened a new Canna Cabana store at 3148 Kingston Road in Scarborough, Ontario on February 9, 2026, bringing the chain to 219 locations in Canada and 95 in Ontario. The site is on a high‑traffic corridor with limited nearby cannabis competition.
The company also granted 145,500 stock options at $3.22 exercisable until February 6, 2029, and 1,300,530 RSUs with staged vesting through February 6, 2029; 795,106 RSUs were granted to directors as a related‑party transaction exempt under MI 61‑101.
High Tide (Nasdaq: HITI) reported record Q4 revenue of $164.0M and a fiscal 2025 revenue run-rate > $650M, with record Adjusted EBITDA of $12.4M in Q4 and annual free cash flow of $12.0M. The company added 34 Canna Cabana stores in calendar 2025 to reach 218 locations and closed a 51% acquisition of Remexian Pharma to enter the German medical cannabis market.
Q4 same-store sales rose 5.5% YoY (4.1% for fiscal 2025), gross profit was $42.5M (26% margin), and cash and cash equivalents were $47.9M as at Oct 31, 2025.